BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25965260)

  • 21. Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.
    Mollica A; Costante R; Akdemir A; Carradori S; Stefanucci A; Macedonio G; Ceruso M; Supuran CT
    Bioorg Med Chem; 2015 Sep; 23(17):5311-8. PubMed ID: 26264840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
    Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives.
    Taslimi P; Gulcin I; Ozgeris B; Goksu S; Tumer F; Alwasel SH; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(1):152-7. PubMed ID: 25697270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids.
    Winum JY; Innocenti A; Scozzafava A; Montero JL; Supuran CT
    Bioorg Med Chem; 2009 May; 17(10):3649-52. PubMed ID: 19375921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes.
    Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT
    Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII.
    Angapelly S; Sri Ramya PV; Angeli A; Supuran CT; Arifuddin M
    ChemMedChem; 2017 Oct; 12(19):1578-1584. PubMed ID: 28940980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
    Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors.
    Winum JY; Innocenti A; Nasr J; Montero JL; Scozzafava A; Vullo D; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2353-8. PubMed ID: 15837324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B; Ceruso M; Carta F; Supuran CT
    Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II.
    Maresca A; Supuran CT
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4511-4. PubMed ID: 20580555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII.
    Grandane A; Tanc M; Zalubovskis R; Supuran CT
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1256-60. PubMed ID: 24518190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives.
    Işık S; Vullo D; Durdagi S; Ekinci D; Şentürk M; Çetin A; Şentürk E; Supuran CT
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5636-41. PubMed ID: 26520662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library.
    Davis RA; Innocenti A; Poulsen SA; Supuran CT
    Bioorg Med Chem; 2010 Jan; 18(1):14-8. PubMed ID: 19962903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX.
    Abbate F; Casini A; Owa T; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Jan; 14(1):217-23. PubMed ID: 14684331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
    Winum JY; Dogné JM; Casini A; de Leval X; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    J Med Chem; 2005 Mar; 48(6):2121-5. PubMed ID: 15771455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.